Compounds of this invention are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinophathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.
本发明的化合物是非肽类、可逆的第2型蛋
氨酸
氨肽酶
抑制剂,可用于治疗由血管生成介导的疾病,如癌症、血管瘤、增殖性视网膜病变、类风湿关节炎、动脉粥样硬化性新生血管生成、
银屑病、眼部新生血管生成和肥胖症。